Glimda Mv 2mg Tablet (Voglibose 0.2 Mg +Glimepiride 2.0 Mg+Metformin Hydrochloride 500.0 Mg)

Composition:
Each film-coated tablet contains:

Glimepiride IP 2 mg,Metformin Hydrochloride IP 500 mg,Voglibose IP 0.2 mg

Description:
Glimda MV 2 Tablet is an oral antidiabetic combination used to manage type 2 diabetes mellitus when single-drug therapy is inadequate.

Warnings and Precautions:

Take the tablet just before meals to prevent hypoglycemia.

Monitor blood glucose and HbA1c levels regularly.

Use cautiously in patients with renal, hepatic, or cardiac impairment.

Avoid excessive alcohol intake as it may cause lactic acidosis (from metformin) or hypoglycemia.

Not recommended during pregnancy or lactation unless prescribed.

Adverse Effects:
Hypoglycemia, gastrointestinal disturbances (nausea, diarrhea, abdominal pain), metallic taste, or flatulence.
Rarely, lactic acidosis or elevated liver enzymes may occur.

Storage:
Store below 30°C in a cool, dry place, protected from light and moisture.
Keep out of reach of children.